Close
Back to EDIT Stock Lookup

Editas Medicine (EDIT) – Hot FDA News

Nov 17, 2022 09:34 AM Editas Medicine (EDIT) Declines 18% Following Proof of Concept of EDIT-101 from Phase 1/2 BRILLIANCE Trial
Sep 29, 2021 09:06 AM Editas Medicine (EDIT) Declines 12.5% Following Clinical Data from Ongoing Phase 1/2 BRILLIANCE Clinical Trial of EDIT-101 for LCA10
Sep 29, 2021 09:01 AM
Aug 24, 2020 08:32 AM
Dec 12, 2017 05:57 AM
Sep 26, 2017 04:04 PM

Back to EDIT Stock Lookup